Product Information

VARENICLINE 0.5 MG TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.3273 per EA under NDC 68462089356. Its NADAC has been published 163 times since Oct 11, 2023.

FDA first approved this application on Aug 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the varenicline tartrate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

VARENICLINE 0.5 MG TABLET

varenicline tartrate
$0.3273per EA
Low Outlier

Strength

.5 mg/1

NDC

68462089356

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VARENICLINE TARTRATE

Approval Type

Generic (ANDA)

FDA Application

ANDA214255

FDA Approved

8/1/2023

TE Code

AB

On Market Since

8/22/2023

Pharmacological Classes

Cholinergic Agonists
Cholinergic Receptor Agonist
Partial Cholinergic Nicotinic Agonist
Partial Cholinergic Nicotinic Agonists

Price Statistics

The NADAC for VARENICLINE 0.5 MG TABLET has been published 163 times since Oct 11, 2023, and over the history we have for it it has declined 92.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3273 per EA
All-time high$4.6410 (Oct 11, 2023)
All-time low$0.2870 (Oct 21, 2026)
52-week high$0.3802
52-week low$0.2870
Median price$0.6393
Average price$1.0705
Largest weekly change-53.1% (Jul 17, 2024)
Weeks tracked163
Tracking sinceOct 11, 2023

Price History

1W

+14.0%

1M

+5.0%

3M

-2.7%

6M

-2.9%

1Y

-13.9%

3Y

-91.7%

5Y

N/A

All

-92.9%

Generic Alternatives

The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VARENICLINE 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VARENICLINE 0.5 MG TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.3273 per EA (NDC 68462089356), effective Nov 18, 2026.

How has the price of VARENICLINE 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for VARENICLINE 0.5 MG TABLET has declined 92.9%. It has been tracked across 163 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for VARENICLINE 0.5 MG TABLET?

Since Oct 11, 2023, the NADAC for VARENICLINE 0.5 MG TABLET has ranged from a low of $0.2870 (Oct 21, 2026) to a high of $4.6410 (Oct 11, 2023), with a median of $0.6393 per EA.

Are there cheaper alternatives to VARENICLINE 0.5 MG TABLET?

5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VARENICLINE 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures VARENICLINE 0.5 MG TABLET?

VARENICLINE 0.5 MG TABLET (NDC 68462089356) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.